Mannose-Binding Lectin 2 Gene and Risk of Adult Glioma

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Michaud, Dominique S ^a,b   Siddiq, Afshan ^b   Cox, David G ^b,c   Backes, Danielle M ^a   Calboli, Federico C F ^b   Sughrue, Michael E ^d   Gaziano, J Michael ^e   Ma, Jing ^e   Stampfer, Meir ^e,f   Tworoger, Shelley S ^e,f   Hunter, David J ^e,f   Camargo, Carlos A ^e,f,g   Parsa, Andrew T ^h  

^a BROWN UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MANNOSE BINDING LECTIN 2;

AGED; ALLELE; ARTICLE; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GLIOMA; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; NEUROPATHOLOGY; PHENOTYPE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876315308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061117     Document Type: Article

References (32)

1. CBTRUS (2010) Statistical Report: Primary Brain Tumors in the United States, 2004-2006.: Central Brain Tumor Registry of the United States.
2. Ohgaki H, (2009) Epidemiology of brain tumors. Methods Mol Biol 472: 323-342.
3. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
4. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
5. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, et al. (2011) Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 20: 2897-2904.
6. Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT, (2010) Cancer and the complement cascade. Mol Cancer Res 8: 1453-1465.
7. Heitzeneder S, Seidel M, Forster-Waldl E, Heitger A, (2012) Mannan-binding lectin deficiency- Good news, bad news, doesn't matter? Clin Immunol 143: 22-38.
8. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194: 781-795.
9. Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RA, (2005) Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 174: 3220-3226.
10. Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, et al. (1991) Molecular basis of opsonic defect in immunodeficient children. Lancet 337: 1569-1570.
11. Garred P, Larsen F, Madsen HO, Koch C, (2003) Mannose-binding lectin deficiency-revisited. Mol Immunol 40: 73-84.
12. Bernig T, Boersma BJ, Howe TM, Welch R, Yadavalli S, et al. (2007) The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. Carcinogenesis 28: 828-836.
13. Baccarelli A, Hou L, Chen J, Lissowska J, El-Omar EM, et al. (2006) Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 119: 1970-1975.
14. Wang FY, Tahara T, Arisawa T, Shibata T, Yamashita H, et al. (2008) Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population. Dig Dis Sci 53: 2904-2908.
15. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, et al. (2012) 3′-UTR and Functional Secretor Haplotypes in Mannose-Binding Lectin 2 Are Associated with Increased Colon Cancer Risk in African Americans. Cancer Res 72: 1467-1477.
16. Segat L, Crovella S, Comar M, Milanese M, Zanotta N, et al. (2009) MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer. Hum Immunol 70: 436-439.
17. Pine SR, Mechanic LE, Ambs S, Bowman ED, Chanock SJ, et al. (2007) Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 99: 1401-1409.
18. Ytting H, Christensen IJ, Steffensen R, Alsner J, Thiel S, et al. (2011) Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Scand J Immunol 73: 122-127.
19. Stampfer MJ, Buring JE, Willett W, Rosner B, Eberlein K, et al. (1985) The 2×2 factorial design: its application to a randomized trial of aspirin and carotene in US physicians. Statistics Med 4: 111-116.
20. Belanger CF, Hennekens CH, Rosner B, Speizer FE, (1978) The Nurses' Health Study. Am J Nurs 78: 1039-1040.
21. Rimm EB, Giovannucci E, Willett WC, et al. (1991) Alcohol and mortality. Lancet 338: 1073-1074.
22. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
23. Li Q, Yu K, (2008) Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genet Epidemiol 32: 215-226.
24. Rich-Edwards JW, Corsano KA, Stampfer MJ, (1994) Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 140: 1016-1019.
25. Stram DO, Leigh Pearce C, Bretsky P, Freedman M, Hirschhorn JN, et al. (2003) Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 55: 179-190.
26. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, et al. (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53: 79-91.
27. Guimaraes V, Guimaraes R, Brandao L, Baldez da Silva MF, Milanese M, et al. (2008) Association between MBL2 gene functional polymorphisms and high-risk human papillomavirus infection in Brazilian women. Hum Immunol 69: 273-278.
28. Brown EE, Zhang M, Zarin-Pass R, Bernig T, Tseng FC, et al. (2008) MBL2 and hepatitis C virus infection among injection drug users. BMC Infect Dis 8: 57.
29. Comar M, Segat L, Crovella S, Bovenzi M, Cortini E, et al. (2011) The significance of mannose-binding lectin gene polymorphisms on the risk of BK virus coinfection in women with human papillomavirus-positive cervical lesions. Hum Immunol 72: 663-666.
30. Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, et al. (2003) Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 33: 2853-2863.
31. van Kempen LC, de Visser KE, Coussens LM, (2006) Inflammation, proteases and cancer. Eur J Cancer 42: 728-734.
32. Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, et al. (2011) Prediagnostic Plasma IgE Levels and Risk of Adult Glioma in Four Prospective Cohort Studies. J Natl Cancer Inst 103: 1588-1595.